| 3HB4 | date | ![]() |
|||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| authors | |||||||||||||||
| compound | source | ||||||||||||||
| symmetry |
| ||||||||||||||
| crystal cell |
| ||||||||||||||
| method | X-Ray Diffraction | resolution | |||||||||||||
| ligand | E2B BindingDB | enzyme |
| ||||||||||||
| Gene Ontology |
| ||||||||||||||
| Primary reference | Binary and ternary crystal structure analyses of a novel inhibitor with 17beta-HSD type 1: a lead compound for breast cancer therapy., Mazumdar M, Fournier D, Zhu DW, Cadot C, Poirier D, Lin SX, Biochem J. 2009 Dec 10;424(3):357-66. PMID:19929851 | ||||||||||||||
| Data retrieval |
![]() |
| View 3HB4 in 3D |
Proteopedia, because life has more than 2D. |
| Structure-derived information |
| Sequence-derived information |
|
OCA© by Jaime Prilusky, 1996-2014,2022,2024 Bioinformatics Unit Weizmann Institute of Science |